These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10670395)

  • 41. Alternate-day statin therapy for the treatment of hyperlipidemia.
    Reindl EK; Wright BM; Wargo KA
    Ann Pharmacother; 2010 Sep; 44(9):1459-70. PubMed ID: 20702760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combining niacin with statins: does it help heart health?
    Johns Hopkins Med Lett Health After 50; 2011 Dec; 23(10):1-2. PubMed ID: 22216465
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia.
    Iliadis EA; Rosenson RS
    Clin Cardiol; 1999 Jan; 22(1):25-8. PubMed ID: 9929751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
    Virani SS; Ballantyne CM
    Curr Opin Lipidol; 2010 Apr; 21(2):165-6. PubMed ID: 20616632
    [No Abstract]   [Full Text] [Related]  

  • 45. Association of serum lipid indices and statin consumption with periodontal status.
    Sayar F; Fallah S; Akhondi N; Jamshidi S
    Oral Dis; 2016 Nov; 22(8):775-780. PubMed ID: 27426870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Drug combination therapies for patients with hyperlipidemia and its significance].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133
    [No Abstract]   [Full Text] [Related]  

  • 47. [Dietary intervention in hyperlipidemia. Experience in general practice].
    Raabe HC
    Fortschr Med; 1994 Mar; 112(7):85-6. PubMed ID: 8175097
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia.
    O'Keefe JH; Harris WS; Nelson J; Windsor SL
    Am J Cardiol; 1995 Sep; 76(7):480-4. PubMed ID: 7653448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug therapy of hyperlipidemia.
    Prihoda JS; Illingworth DR
    Curr Probl Cardiol; 1992 Sep; 17(9):545-605. PubMed ID: 1446461
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and cost benefits of medical nutrition therapy by registered dietitian nutritionists for management of dyslipidemia: A systematic review and meta-analysis.
    Sikand G; Cole RE; Handu D; deWaal D; Christaldi J; Johnson EQ; Arpino LM; Ekvall SM
    J Clin Lipidol; 2018; 12(5):1113-1122. PubMed ID: 30055973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase or decrease of HDL-cholesterol concentrations during pravastatin treatment depending on the pre-treatment HDL cholesterol levels.
    Narita Y; Kitazoe Y; Kurihara Y; Okuhara Y; Takamatsu K; Saito N; Doi Y
    Eur J Clin Pharmacol; 1997; 52(6):461-3. PubMed ID: 9342581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP; Arriola OG
    Pharmacotherapy; 1997; 17(6):1296-9. PubMed ID: 9399614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults.
    Davis W; Rockway S; Kwasny M
    Am J Ther; 2009; 16(4):326-32. PubMed ID: 19092644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non-alcoholic hepatic steatosis: the role of policosanols in associated hyperlipidemia].
    Musto D; Martorelli L; Russo M; Esposito G; Amato MR; Esposito P; Riegler G
    Minerva Gastroenterol Dietol; 2010 Dec; 56(4):389-95. PubMed ID: 21139538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on pediatric hyperlipidemia.
    Chauhan A; Paunikar P
    Curr Opin Pediatr; 2014 Apr; 26(2):252-8. PubMed ID: 24553633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical Nutrition Therapy Provided by Dietitians is Effective and Saves Healthcare Costs in the Management of Adults with Dyslipidemia.
    Sikand G; Handu D; Rozga M; de Waal D; Wong ND
    Curr Atheroscler Rep; 2023 Jun; 25(6):331-342. PubMed ID: 37165278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of pravastatin on plasma lipid concentrations in poloxamer 407-induced hyperlipidemic rats.
    Porter JA; Carter BL; Johnson TP; Palmer WK
    Pharmacotherapy; 1995; 15(1):92-8. PubMed ID: 7739951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of CRP preparation on serum lipids in patients with hyperlipidemia].
    Białkowska M; Szostak WB; Nowicka G; Szostak-Wegierek D
    Wiad Lek; 1993 May; 46(9-10):351-5. PubMed ID: 8236991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dietitian-delivered group nutrition program leads to reductions in dietary fat, serum cholesterol, and body weight: the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH).
    Hebert JR; Ebbeling CB; Ockene IS; Ma Y; Rider L; Merriam PA; Ockene JK; Saperia GM
    J Am Diet Assoc; 1999 May; 99(5):544-52. PubMed ID: 10333775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterol.
    Dolecek TA; Bradham KH; Espeland MA; Margitic SE; Byington RP; Hoen H; Kappelle LJ
    Control Clin Trials; 1996 Feb; 17(1):33-45. PubMed ID: 8721800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.